analytical standard is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-11-16. Numbers and descriptions here follow the published literature rather than marketing material.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
=== White's Fort === In 1786, White moved to the future site of Knoxville, where he and fellow explorer James Connor built what became known as White's Fort. The site straddled a hill that was bounded by the river on the south, creeks (First Creek and Second Creek) on the east and west, and a swampy declivity on the north. The fort, which originally stood along modern State Street, consisted of four heavily timbered cabins connected by an 8-foot (2.4 m) palisade, enclosing one-quarter acre of ground. White also erected a mill for grinding grain on nearby First Creek. White's Fort represented the western extreme of the so-called State of Franklin, which Tennessee settlers organized in 1784 after North Carolina reneged on its plans to cede its western territory to the federal government. James White supported the State of Franklin, and served as its Speaker of the Senate in 1786. The federal government never recognized the State of Franklin, however, and by 1789, its supporters once again pledged allegiance to North Carolina. In 1789, White, William Blount, and former State of Franklin leader John Sevier, now members of the North Carolina state legislature, helped convince the state to ratify the United States Constitution. Following ratification, North Carolina ceded control of its Tennessee territory to the federal government. In May 1790, the United States created the Southwest Territory, which included Tennessee, and President George Washington appointed Blount the territory's governor.
== CCN protein family == CCN1 was first identified as a protein encoded by a serum-inducible gene in mouse fibroblasts. Other highly conserved homologs were later identified to comprise the CCN protein family (CCN intercellular signaling protein). The CCN acronym is derived from the first three members of the family identified, namely CYR61 (CCN1), CTGF (connective tissue growth factor, or CCN2), and NOV (nephroblastoma overexpressed, or CCN3). These proteins, together with WISP1 (CCN4), WISP2 (CCN5), and WISP3 (CCN6) comprise the six members of the family in vertebrates and have been renamed CCN1-6 in order of their discovery by international consensus. CCN proteins function as matricellular proteins, which are extracellular matrix proteins that play regulatory roles, particularly in the context of wound repair.
Retailing in India is a pillar of the national economy accounting for about 10 percent of GDP. The Indian retail market is estimated to be worth $1.3 trillion as of 2022. India is one of the fastest growing retail markets in the world, with 1.4 billion people. As of 2003, India's retailing industry was essentially owner staffed small shops. In 2010, larger format convenience stores and supermarkets accounted for about 4 percent of the industry, and these were present only in large urban centers. India's retail and logistics industry employs about 40 million Indians (3.3% of Indian population). In November 2011, India's central government announced retail reforms for both multi-brand stores and single-brand stores. These market reforms paved the way for retail innovation and competition with multi-brand retailers such as Walmart, Carrefour and Tesco, as well single brand majors such as IKEA, Nike, and Apple. The announcement sparked intense activism, both in opposition and in support of the reforms. In December 2011, under pressure from the opposition, Indian government placed the retail reforms on hold until a consensus was reached. In January 2012, India approved reforms for single-brand stores welcoming anyone in the world to innovate in Indian retail market with 100% ownership, but imposed the requirement that the single brand retailer source 30 percent of its goods from India. Indian government continues the hold on retail reforms for multi-brand stores.
In the early 19th century, the British sought to reform the settlers, threatening to suspend the Public Meeting unless it observed the government's instructions to eliminate slavery outright. After a generation of wrangling, slavery was abolished in the British Empire in 1833. As a result of their enslaved Africans' abilities in the work of mahogany extraction, owners in British Honduras were compensated £53.34 per enslaved African on average (equivalent to £5,100 in 2025), the highest amount paid in any British territory. The end of slavery did little to change the formerly enslaved Africans' working conditions if they stayed at their trade. A series of institutions restricted the ability of emancipated African individuals to buy land, in a debt-peonage system. Former "extra special" mahogany or logwood cutters undergirded the early ascription of the capacities (and consequently the limitations) of people of African descent in the colony. Because a small elite controlled the settlement's land and commerce, formerly enslaved Africans had little choice but to continue to work in timber cutting. In 1836, after the emancipation of Central America from Spanish rule, the British claimed the right to administer the region. In 1862, the United Kingdom formally declared it a British Crown Colony, subordinate to Jamaica, and named it British Honduras. Since 1854, the richest inhabitants elected an assembly of notables by censal vote, which was replaced by a legislative council appointed by the British government. As a colony, Belize began to attract British investors.
=== Alternative medicine === A 2018 Cochrane review on acupuncture and related interventions for the treatment of carpal tunnel syndrome concluded that "Acupuncture and laser acupuncture may have little or no effect in the short term on symptoms of carpal tunnel syndrome (CTS) in comparison with placebo or sham acupuncture." It was also noted that all studies had an unclear or high overall risk of bias and that all evidence was of low or very low quality.
Sources: en.wikipedia.org
Davis who developed and patented of the real-time single particle mass spectrometry (RTSPMS) instrument. The setup is quite similar to today's AMS system, with the sample being introduced through a small steel capillary into the ion source region. The sample would ionize after striking a hot rhenium filament. The resulting ions were separated in a magnetic sector and detected by an electron multiplier. The method could only ionize elements with ionization potentials below the work function of the filament (~8 eV), typically alkali and alkaline earth metal. The instrument did yield unit resolution up to a mass-to-charge ratio of 115. The RTSPMS instrument had a particle transmission/detection efficiency of 0.2-0.3%. Davis used the RTSPMS instrument to study samples from calibration aerosols, ambient laboratory air, and aerosols sources. Majority of his studies where focused on inorganic salts created in lab. In Davis's analysis of ambient air, he found a significant increase in lead at the end of the day, which was concluded to be due to automobile emissions. This development was the first step towards, today's modern on-line instruments. The next major development in technological improvement that came out of the 1970s was in 1976 by Stoffel with the development of a magnetic sector RTSPMS technique that had a direct-inlet mass spectrometry (DIMS) also known as particle-inlet mass spectrometry (PIMS).
=== Mechanism of action === Fabry disease is a genetic disorder caused by various mutations of the enzyme α-GalA, which is responsible for breaking down the sphingolipid globotriaosylceramide (Gb3), among other glycolipids and glycoproteins. Some of these mutations result in misfolding of α-GalA, which subsequently fails protein quality control in the endoplasmic reticulum and is decomposed. Lack of functional α-GalA leads to accumulation of Gb3 in blood vessels and other tissues, with a wide range of symptoms including kidney, heart, and skin problems. Migalastat is a potent, orally available inhibitor of α-GalA (IC50: 4 μM). When binding to faulty α-GalA, it shifts the folding behaviour towards the proper conformation, resulting in a functional enzyme provided the mutation is amenable. Molecules with this type of mechanism are called pharmacological chaperones. When the enzyme reaches its destination, the lysosome, migalastat dissociates because of the low pH and the relative abundance of Gb3 and other substrates, leaving α-GalA free to fulfill its function. Depending on the mutation, the EC50 is between 0.8 μM and over 1 mM in cellular models.
=== Radiation therapy === Radiation therapy is the most frequently used treatment for hypersomatotropic cats. Radiation therapy is expensive, limited in availability, cost, frequent anaesthetic, and the unpredictable outcomes for hormonal control. The resolution or improvement of neurological signs is the most consistent effect. Improvement diabetes symptoms is less consistent. One study found an average of 5 weeks for improvement to glycaemic control with all cats seeing an improvement within 20 weeks. The same study found 6 of the 14 cats to achieve diabetic remission within 6 months with an average of 3.6 months. Diabetic remission may occur as late as a year after radiotherapy. Improvement of diabetic symptoms occurs in roughly 70-80% of cases, diabetic remission occurs in roughly 50%. The physical acromegalic changes often persistent or have only slight improvement. High IGF-1 levels have been reported in cats following radiation therapy. Of note is that in several of those cases the patient had good control of diabetic symptoms or was in remission. Radiation therapy is tolerated by the majority of cats. Side effects such as ischaemic brain necrosis and hearing loss are rare and proper fractionation protocol can prevent these effects from occurring; hypopituitarism has not been reported in cats, despite being a common adverse effect in humans. Survival times for cats after radiation therapy has been reported to be up to 5 years.
=== Development === The project started with producer Mace Neufeld, and was intended as a prestige thriller headlined by James Caan but that version stalled due to difficulties with the script. Neufeld later partnered with Moshe Diamant to pitch it, under the title Heart of Stone, to football player and aspiring actor Brian Bosworth. Diamant's Epic Productions had formed a joint venture with Michael Douglas and Rick Bieber's Stonebridge Entertainment called the Stone Group and the Douglas connection was an added incentive to Bosworth. Joining the other executive producers was Gary Wichard, Bosworth's personal manager who had spearheaded his transition to movies. Producer duties were entrusted to Yoram Ben Ami, CEO of Triumph Releasing, a Columbia Pictures subsidiary that usually dealt with Diamant's product. During pre-production, the screenplay was attributed to Walter Doninger and Howard Cushnir (the latter is absent from the final credits). It was retooled for Bosworth, who consulted with the writers over about one year. A late pre-production report claimed that the story was to be set in the Midwest. However, Ben Ami indicated that the Deep South region had been chosen because it was in the script, and some of the eventual locations had been in talks to host since at least summer 1989.
The slime coat (also fish slime, mucus layer or slime layer) is the coating of mucus covering the body of all fish. An important part of fish anatomy, it serves many functions, depending on species, ranging from locomotion, care and feeding of offspring, to resistance against diseases and parasites. The mucin making up the slime coat is secreted by goblet cells in the fish's epidermis. The slime contains a variety of antimicrobial peptides and other antimicrobial components such as lysozyme and C-reactive protein. It contains mycosporine-like amino acids to protect from ultraviolet radiation.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.